SOX2 and lung adenocarcinoma: Wilbertz et al. investigated SOX2 amplifications and expression in two cohorts and reported no association between SOX2 expression and survival in lung adenocarcinoma; however, observed a decreased survival in patients with low-level amplifications in one of the cohorts [15].